bearish

Anti-Corruption in China Healthcare – the Impact and the Outlook

706 Views01 Aug 2023 09:10
This year's anti-corruption campaign against the entire healthcare industry has risen to the highest level. Although the impact on listed companies is indirect, it deserves investors' more attention.
Boomeranged on Mon, 7 Aug 2023 13:00
The share prices of China healthcare are now plummeting due to anti-corruption campaign, which will reach a climax in 23H2 (We'll post updates in weekly report). That means share price would continue to fall. However, many stocks that used to be overvalued will become cheap, which means investors can long at low prices, because there will be a rebound afterwards, especially medical device sector.
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 3-minute read)
Discussions
(Paid Plans Only)
chart-bar
x